Detalles de la búsqueda
1.
A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies.
J Virol
; 95(9)2021 04 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33597214
2.
A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response.
J Infect Dis
; 214(6): 832-5, 2016 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26908742
3.
Infant antibody and B-cell responses following confirmed pediatric GII.17 norovirus infections functionally distinguish GII.17 genetic clusters.
Front Immunol
; 14: 1229724, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37662930
4.
UV decontamination of personal protective equipment with idle laboratory biosafety cabinets during the COVID-19 pandemic.
PLoS One
; 16(7): e0241734, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34310599
5.
Kinetics and Isotype Assessment of Antibodies Targeting the Spike Protein Receptor Binding Domain of SARS-CoV-2 In COVID-19 Patients as a function of Age and Biological Sex.
medRxiv
; 2020 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32743592
6.
Kinetics and isotype assessment of antibodies targeting the spike protein receptor-binding domain of severe acute respiratory syndrome-coronavirus-2 in COVID-19 patients as a function of age, biological sex and disease severity.
Clin Transl Immunology
; 9(10): e1189, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33072323
7.
Human antibody response to Zika targets type-specific quaternary structure epitopes.
JCI Insight
; 4(8)2019 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30996133
8.
Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus.
PLoS Negl Trop Dis
; 12(10): e0006862, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30356267
9.
In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination.
PLoS Negl Trop Dis
; 11(5): e0005584, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28481883
Resultados
1 -
9
de 9
1
Próxima >
>>